Human IFN gamma ELISA Kit (RMEK-0152682)
Cat. No.: RMEK-0152682
Category: ELISA Kits
INQUIRY
1 x 96 tests
Human IFN gamma ELISA kit is a single-wash 90 min sandwich ELISA designed for the quantitative measurement of IFN-gamma protein in human cell culture supernatant, plasma and serum samples. The technology. Quantitate human IFN gamma with 470 pg/mL sensitivity.
Product Features
| Species Reactivity | Human |
|---|---|
| Detection Method | Colorimetric |
| Assay Duration | One step assay |
| Assay Time | 1.5 h |
| Assay Type | Sandwich (quantitative) |
| Precision | Intra-Assay-Overall-5-1.1%; Inter-Assay-Overall-3-7.9% |
| Sensitivity | 470 pg/mL |
| Range | 0.468 ng/mL - 30 ng/mL |
| Sample Type | Cell culture supernatant, Plasma, Serum |
| Recovery | Serum-102-98% - 104%; Cell culture media-86-77% - 93%; Hep Plasma-244-197% - 298%; EDTA Plasma-122-117% - 124%; Cit plasma-107-96% - 115% |
| Key Features | One-wash 90 minute protocol; Sensitivity: 470 pg/mL; Range: 0.468 ng/mL - 30 ng/mL; Sample type: Cell culture supernatant, Plasma, Serum; Detection method: Colorimetric; Assay type: Sandwich (quantitative); Reacts with: Human |
Target Information
| Target Symbol | IFNG |
|---|---|
| UniProt ID | P01579 |
| Function | Produced by lymphocytes activated by specific antigens or mitogens. IFN-gamma, in addition to having antiviral activity, has important immunoregulatory functions. It is a potent activator of macrophages, it has antiproliferative effects on transformed cells and it can potentiate the antiviral and antitumor effects of the type I interferons. |
| Cellular Localization | Secreted. |
| Post-transcriptional Modifications | Proteolytic processing produces C-terminal heterogeneity, with proteins ending alternatively at Gly-150, Met-157 or Gly-161. |
| Involvement in Disease | In Caucasians, genetic variation in IFNG is associated with the risk of aplastic anemia (AA). AA is a rare disease in which the reduction of the circulating blood cells results from damage to the stem cell pool in bone marrow. In most patients, the stem cell lesion is caused by an autoimmune attack. T-lymphocytes, activated by an endogenous or exogenous, and most often unknown antigenic stimulus, secrete cytokines, including IFN-gamma, which would in turn be able to suppress hematopoiesis. |
Storage & Shipping
| Storage | Store at 2-8°C |
|---|---|
| Shipping | Gel Packs |
| Stability | The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition. |
For research use only. Not for clinical use.
